122 related articles for article (PubMed ID: 14647249)
1. Herpes simplex virus infection in adult patients after unrelated cord blood transplantation: a single-institute experience in Japan.
Tomonari A; Takahashi S; Iseki T; Ooi J; Yamada T; Takasugi K; Shimohakamada Y; Ohno N; Nagamura F; Uchimaru K; Tani K; Tojo A; Asano S
Bone Marrow Transplant; 2004 Feb; 33(3):317-20. PubMed ID: 14647249
[TBL] [Abstract][Full Text] [Related]
2. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Yamaguchi T; Tojo A; Asano S
Eur J Haematol; 2008 Mar; 80(3):251-7. PubMed ID: 18081702
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
[TBL] [Abstract][Full Text] [Related]
6. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.
Ooi J; Takahashi S; Tomonari A; Tsukada N; Konuma T; Kato S; Kasahara S; Sato A; Monma F; Nagamura F; Iseki T; Tojo A; Asano S
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1341-7. PubMed ID: 19041055
[TBL] [Abstract][Full Text] [Related]
7. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ
Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
9. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
Cornetta K; Laughlin M; Carter S; Wall D; Weinthal J; Delaney C; Wagner J; Sweetman R; McCarthy P; Chao N
Biol Blood Marrow Transplant; 2005 Feb; 11(2):149-60. PubMed ID: 15682076
[TBL] [Abstract][Full Text] [Related]
10. Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease.
Gratama JW; Sinnige LG; Weijers TF; Zwaan FE; van Heugten JG; Stijnen T; D'Amaro J; The TH; Hekker AC; de Gast GC
Exp Hematol; 1987 Aug; 15(7):735-40. PubMed ID: 3038583
[TBL] [Abstract][Full Text] [Related]
11. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
[TBL] [Abstract][Full Text] [Related]
12. Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age.
Konuma T; Takahashi S; Ooi J; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Kasahara S; Nagamura-Inoue T; Uchimaru K; Iseki T; Tojo A; Yamaguchi T; Asano S
Ann Hematol; 2009 Jun; 88(6):581-8. PubMed ID: 19030858
[TBL] [Abstract][Full Text] [Related]
13. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
Okada M; Fujimori Y; Misawa M; Kai S; Nakajima T; Okikawa Y; Satake A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Tamaki H; Ikegame K; Hara H; Ogawa H
Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
[TBL] [Abstract][Full Text] [Related]
14. Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years.
Ooi J; Iseki T; Takahashi S; Tomonari A; Takasugi K; Uchiyama M; Konuma T; Futami M; Nomura A; Nakayama S; Soda Y; Ohno N; Nagamura F; Uchimaru K; Tojo A; Tani K; Asano S
Br J Haematol; 2004 Sep; 126(5):711-4. PubMed ID: 15327524
[TBL] [Abstract][Full Text] [Related]
15. Early infections in adult patients undergoing unrelated donor cord blood transplantation.
Saavedra S; Sanz GF; Jarque I; Moscardó F; Jiménez C; Lorenzo I; Martín G; Martínez J; De La Rubia J; Andreu R; Mollá S; Llopis I; Fernández MJ; Salavert M; Acosta B; Gobernado M; Sanz MA
Bone Marrow Transplant; 2002 Dec; 30(12):937-43. PubMed ID: 12476288
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic peripheral blood stem cell transplantations in children--a single center experience.
Sufliarska S; Horáková J; Bodová I; Martinka J; Hrubisko M; Kovács L; Jancovicová K; Lukác J
Neoplasma; 2004; 51(2):110-6. PubMed ID: 15190420
[TBL] [Abstract][Full Text] [Related]
17. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance.
Chakrabarti S; Pillay D; Ratcliffe D; Cane PA; Collingham KE; Milligan DW
J Infect Dis; 2000 Jun; 181(6):2055-8. PubMed ID: 10837192
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients.
Narimatsu H; Matsumura T; Kami M; Miyakoshi S; Kusumi E; Takagi S; Miura Y; Kato D; Inokuchi C; Myojo T; Kishi Y; Murashige N; Yuji K; Masuoka K; Yoneyama A; Wake A; Morinaga S; Kanda Y; Taniguchi S
Biol Blood Marrow Transplant; 2005 Jun; 11(6):429-36. PubMed ID: 15931631
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
Sugimoto K; Narimatsu H; Kawase T; Iida H; Watanabe M; Kohno A; Kuwatsuka Y; Uchida T; Hamaguchi M; Terakura S; Naoe T; Matsuo K; Murata M; Sawa M; Miyamura K; Morishita Y;
Bone Marrow Transplant; 2008 Apr; 41(8):729-36. PubMed ID: 18176617
[TBL] [Abstract][Full Text] [Related]
20. Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.
Yüksel M; Baron E; Camouse M; Cooper BW; Lazarus HM; Gerson SL; Laughlin MJ; Cooper KD; Gilliam A; Fu P; Stevens S; Koç ON
Biol Blood Marrow Transplant; 2006 Jun; 12(6):665-71. PubMed ID: 16737940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]